Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas L Fletcher

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Molecular Pharmaceutics|January 5, 2023
Pharmacokinetics and Biodistribution of <sup>89</sup>Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in GlioblastomaSaikat Ghosh, Nicholas L Fletcher, Pie Huda, et al.
Frontiers in Bioengineering and Biotechnology|February 4, 2021
Characterization of the Biodistribution of a Silica Vesicle Nanovaccine Carrying a <i>Rhipicephalus (Boophilus) microplus</i> Protective Antigen With <i>in vivo</i> Live Animal ImagingKarishma T Mody, Bing Zhang, Xun Li, et al.
Biomacromolecules|November 27, 2025
PEG-free Lipid Nanoparticles for mRNA Delivery: Superhydrophilic Sulfoxide Polymer CoatingsOn Ting Choy, Nicholas L Fletcher, Changkui Fu, et al.
Communications Chemistry|March 4, 2023
Self-cyclisation as a general and efficient platform for peptide and protein macrocyclisationXinying Jia, Yanni K-Y Chin, Alan H Zhang, et al.
Chemical Science|August 2, 2024
A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elementsJames L Wood, Saikat Ghosh, Zachary H Houston, et al.
Biomacromolecules|September 4, 2015
Evaluation of Polymeric Nanomedicines Targeted to PSMA: Effect of Ligand on Targeting EfficiencyAdrian V Fuchs, Brian W C Tse, Amanda K Pearce, et al.
ACS Nano|September 16, 2020
Controlling the Biological Fate of Micellar Nanoparticles: Balancing Stealth and TargetingAmal J Sivaram, Andri Wardiana, Sheilajen Alcantara, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 13, 2026
Utilizing biorecognition to prime tumors for enhanced nanomedicine delivery of alpha therapiesNicholas L Fletcher, Weijing Chu, Pie Huda, et al.
Scientific Reports|November 5, 2024
A novel immunomodulating peptide with potential to complement oligodeoxynucleotide-mediated adjuvanticity in vaccination strategiesMichael Agrez, Christopher Chandler, Kristofer J Thurecht, et al.
Scientific Reports|November 13, 2023
An immunomodulating peptide with potential to suppress tumour growth and autoimmunityMichael Agrez, Christopher Chandler, Kristofer J Thurecht, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Molecular Pharmaceutics|January 5, 2023
Pharmacokinetics and Biodistribution of <sup>89</sup>Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in GlioblastomaSaikat Ghosh, Nicholas L Fletcher, Pie Huda, et al.
Frontiers in Bioengineering and Biotechnology|February 4, 2021
Characterization of the Biodistribution of a Silica Vesicle Nanovaccine Carrying a <i>Rhipicephalus (Boophilus) microplus</i> Protective Antigen With <i>in vivo</i> Live Animal ImagingKarishma T Mody, Bing Zhang, Xun Li, et al.
Biomacromolecules|November 27, 2025
PEG-free Lipid Nanoparticles for mRNA Delivery: Superhydrophilic Sulfoxide Polymer CoatingsOn Ting Choy, Nicholas L Fletcher, Changkui Fu, et al.
Communications Chemistry|March 4, 2023
Self-cyclisation as a general and efficient platform for peptide and protein macrocyclisationXinying Jia, Yanni K-Y Chin, Alan H Zhang, et al.
Chemical Science|August 2, 2024
A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elementsJames L Wood, Saikat Ghosh, Zachary H Houston, et al.
Biomacromolecules|September 4, 2015
Evaluation of Polymeric Nanomedicines Targeted to PSMA: Effect of Ligand on Targeting EfficiencyAdrian V Fuchs, Brian W C Tse, Amanda K Pearce, et al.
ACS Nano|September 16, 2020
Controlling the Biological Fate of Micellar Nanoparticles: Balancing Stealth and TargetingAmal J Sivaram, Andri Wardiana, Sheilajen Alcantara, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 13, 2026
Utilizing biorecognition to prime tumors for enhanced nanomedicine delivery of alpha therapiesNicholas L Fletcher, Weijing Chu, Pie Huda, et al.
Scientific Reports|November 5, 2024
A novel immunomodulating peptide with potential to complement oligodeoxynucleotide-mediated adjuvanticity in vaccination strategiesMichael Agrez, Christopher Chandler, Kristofer J Thurecht, et al.
Scientific Reports|November 13, 2023
An immunomodulating peptide with potential to suppress tumour growth and autoimmunityMichael Agrez, Christopher Chandler, Kristofer J Thurecht, et al.
Pageof 7